Background: Mounting evidence demonstrates enhanced systemic levels of inflammatory mediators in depression, indicating that inflammation may play a role in the etiology and …
Objective: Major depressive disorder is the leading cause of disability worldwide. Yet, there remain significant challenges in predicting new cases of major depression and devising …
R Li, X Wang, T Qin, R Qu, S Ma - Behavioural brain research, 2016 - Elsevier
Increasing evidence suggests that inflammation and oxidative stress may contribute to the development of major depressive disorder (MDD). Apigenin, a type of bioflavonoid widely …
M Guo, C Li, Y Lei, S Xu, D Zhao, XY Lu - Molecular psychiatry, 2017 - nature.com
Adaptive responses to stressful stimuli involving behavioral, emotional and metabolic changes are orchestrated by the nervous and endocrine systems. Adipose tissue has been …
Q Zhao, X Wu, S Yan, X Xie, Y Fan, J Zhang… - Journal of …, 2016 - Springer
Background Discoveries that microglia-mediated neuroinflammation is involved in the pathological process of depression provided a new strategy for novel antidepressant …
K Sepanjnia, A Modabbernia, M Ashrafi… - …, 2012 - nature.com
Thiazolidinediones have shown antidepressant effect in animal studies, as well as in some uncontrolled studies evaluating human subjects with concurrent major depressive disorder …
Approximately more than 50% of patients with depression have the co-occurrence of anxiety, which complicates the treatment of disease. Recently, social isolation stress (SIS) …
Background The antidepressive effect of pioglitazone has been noted in patients with major depressive disorder in absence of metabolic syndrome. This study was conducted to …
Major depression and bipolar disorder are heterogeneous conditions in which there can be dysregulation of (1) the stress system response,(2) its capacity for counterregulation after …